Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Intraocular toxoplasmosis mimicking vitreous lymphoma

Ruijun Jeanna Su, Jonathan Said

Blood (2019) 133 (7): 767.

https://doi.org/10.1182/blood-2018-10-883124

Published: 2019

Journal Articles

Opportunistic Infections, Is Non Hodgkin Lymphoma One of the Risk Factors for Mortality?

Karan Jatwani, MBBS, Shraddha Jatwani, MBBS, MD, Sridevi Rajeeve, MD, Karan Chugh, MBBS, MD, Rakesh Kumar Sharma, MBBS, MD, Stuthi Perimbeti, MD MPH, Vivek Suresh Modi, MBBS, Siva Krishna Mannem, MBBS

Blood (2018) 132 (Supplement 1): 5818.

https://doi.org/10.1182/blood-2018-99-120214

Published: 2018

Journal Articles

Neurological Adverse Events Determine Morbidity and Mortality Post Allogeneic Hematopoietic Cell Transplantation

Ioanna Sakellari, Eleni Gavriilaki, MD, Sotirios Papagiannopoulos, Maria Gavriilaki, MD, Ioannis Batsis, Despina Mallouri, Anna Vardi, MD PhD, Varnavas Constantinou, Michalis Iskas, Marianna Masmanidou, Evangelia Yannaki, MD, Triantafyllos Geroukis, MD, Dimitrios Kazis, Vasilis Kimiskidis, Achilles Anagnostopoulos

Blood (2018) 132 (Supplement 1): 5732.

https://doi.org/10.1182/blood-2018-99-112032

Published: 2018

Journal Articles

Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group

Shun-Ichi Kimura, MD PhD, Yoshinobu Kanda, MD PhD, Masaki Iino, MD PhD, Takahiro Fukuda, MD PhD, Emiko Sakaida, MD PhD, Tatsuo Oyake, Hiroki Yamaguchi, MD PhD, Shin-ichiro Fujiwara, MD PhD, Junji Suzumiya, MD PhD, Akinao Okamoto, MD PhD, Hiroyuki Fujita, MD PhD, Yasushi Takamatsu, MD PhD, Yoshio Saburi, MD PhD, Jun Yamanouchi, MD PhD, Itaru Matsumura, MD, Souichi Shiratori, Moritaka Gotoh, MD PhD, Shingen Nakamura, MD PhD, Kazuo Tamura, MD PhD

Blood (2018) 132 (Supplement 1): 816.

https://doi.org/10.1182/blood-2018-99-111154

Published: 2018

Journal Articles

Ruxolitinib Inhibits Toll-like Receptor or GM-CSF, but Not TREM-1 Mediated Neutrophil Activation

Pamela Aranda Lopez, PhD, Astrid Alflen, MD, Nicole Stadler, Cornelia Schmidt, Thomas Kindler, MD, Matthias Theobald, MD PhD, Markus P. Radsak, MD

Blood (2017) 130 (Supplement 1): 4805.

https://doi.org/10.1182/blood.V130.Suppl_1.4805.4805

Published: 2017

Journal Articles

Impact of Somatic Mutations on Clinical Outcomes Following Flamsa-Bu Conditioning and Allogenic Stem Cell Transplantation in Patients with Poor-Risk Myeloid Malignancies

Karl Haslam, MPhil MBA, Niamh Appleby, FRCPath, Christopher Armstrong, MB MRCPI, Catherine M. Flynn, MD MRCP, FRCPath, Stephen Langabeer, PhD FRCPath, Eibhlin Conneally, MB, MRCP, MRCPath, PhD

Blood (2016) 128 (22): 2277.

https://doi.org/10.1182/blood.V128.22.2277.2277

Published: 2016

Journal Articles

Cerebral Toxoplasmosis in a Patient with Prolonged CD4 Lymphopenia Post Autologous Haematopoietic Stem Cell Transplant

Arielle van Mourik, MBBS BBiomedSci, Andrew P Grigg, MBBS MD

Blood (2016) 128 (22): 4902.

https://doi.org/10.1182/blood.V128.22.4902.4902

Published: 2016

Journal Articles

Transplantation from Matched Unrelated and Haploidentical Donor in Pediatric Severe Aplastic Anemia: Experience with TCR Alpha/Beta and CD19 Depletion As Graft Processing Method

Daria Shasheleva, Larisa Shelikhova, MD, Zhanna Shekhovtsova, MD, Dmitriy Balashov, Pavel Trakhtman, Elena Boyakova, MD, Elena Raykina, Elena Kurnikova, MD, Alexey Kazachenok, Varvara Briliantova, Anna Bogoyavlenskaya, Maria Ilyushina, Svetlana Kozlovskaya, Galina Novichkova, MD, Michael Maschan, MD PhD, Alexey Maschan, MD PhD

Blood (2016) 128 (22): 2294.

https://doi.org/10.1182/blood.V128.22.2294.2294

Published: 2016

Journal Articles

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Federico Simonetta, MD PhD, Hélène Labussière-Wallet, MD, Maciej J Machaczka, MD, Flore Sicre de Fontbrune, MD, Michael Medinger, MD, Sylvain Chantepie, MD, Tony Marchand, MD, Stavroula Masouridi-Levrat, MD, Marie-Thérèse Rubio, MD PhD, Oumedaly Reman, MD, Nathalie Dhedin, MD, Loic Fouillard, MD, Olivier Lambotte, MD PhD, Lionel Galicier, MD, Paul Coppo, MD PhD, Jakob Passweg, MD, Ibrahim Yakoub-Agha, MD PhD, Regis Peffault De Latour, MD PhD, Yves Chalandon, MD

Blood (2016) 128 (22): 4617.

https://doi.org/10.1182/blood.V128.22.4617.4617

Published: 2016

Journal Articles

Disease and Therapy Associated Complications of the Central Nervous System after Allogeneic Hematopoietic Cell Transplantation - a Significant Proportion of Patients Will Suffer from Permanent Damage

Sebastian P. Haen, MD, Manfred Zierhut, MD, Nora Mirza, PhD, Christoph M. Simon, MD, Andreas Korn, MD, Christoph Faul, MD, Wichard Vogel, MD, Hans-Georg Rammensee, PhD, Lothar Kanz, MD, Wolfgang Bethge, MD

Blood (2016) 128 (22): 4620.

https://doi.org/10.1182/blood.V128.22.4620.4620

Published: 2016

Journal Articles

Long Term Follow-up of Hematopoietic Stem Cell Transplantation (HSCT) for Primary Plasma Cell Leukemia (pPCL): Final Results of a Prospective Study of IFM Group

Blood (2016) 128 (22): 4612.

https://doi.org/10.1182/blood.V128.22.4612.4612

Published: 2016

Journal Articles

Seroprevalence for Toxoplasma Gondii in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Erden Atilla, MD, Pinar Ataca, MD, Sevinc Balli, MD, Baris Isikoglu, MD, Pervin Topcuoglu, MD, Muhit Ozcan, MD, Hamdi Akan, MD

Blood (2015) 126 (23): 5459.

https://doi.org/10.1182/blood.V126.23.5459.5459

Published: 2015

Journal Articles

Assessment of Incidence Toxoplasma Gondii Infection and Outcomes in Allogeneic Stem Cell Patients

Blood (2014) 124 (21): 1187.

https://doi.org/10.1182/blood.V124.21.1187.1187

Published: 2014

Journal Articles

Specificity of JAK-Kinase Inhibition Determines Impact on T-Cell Function

Florian Perner, Felix C Saalfeld, cand.MD, Tina M Schnoeder, PhD, Denise Wolleschak, MD, Corinna Fahldieck, Satish Ranjan, Berend H Isermann, MD, Katrin Hebel, PhD, Monika Brunner-Weinzierl, PhD, Thomas Fischer, MD, Florian H Heidel, MD

Blood (2014) 124 (21): 1410.

https://doi.org/10.1182/blood.V124.21.1410.1410

Published: 2014

Journal Articles

Neutropenia during Hematopoietic Stem Cell Mobilization with G-CSF

Lezhong Yuan, MD, Hui Liu, Qiang Wang, Jing Sun, MD, Qifa Liu, MD, Hao Huang, MD, Yanyan Ye, Qianli Jiang, PhDMD

Blood (2014) 124 (21): 5835.

https://doi.org/10.1182/blood.V124.21.5835.5835

Published: 2014

Journal Articles

Infectious Complications After Unrelated Donor Allogeneic Hematopoietic Cell Transplantation With Or Without Alemtuzumab Based In Vivo Lymphocyte Depletion

Brian C. Shaffer, MD, Andrew Flynn, David Moorshead, Zach Powell, Jennifer Hsu, RN, Rachel B Salit, MD, Frances T. Hakim, PhD, Ronald E. Gress, MD, Michael Bishop, MD, Juan Gea-Banacloche, MD, Steven Z. Pavletic, MD

Blood (2013) 122 (21): 4580.

https://doi.org/10.1182/blood.V122.21.4580.4580

Published: 2013

Journal Articles

Central Nervous System Complications After Allogeneic Hematopoietic Cell Transplantation – Treatment Related Morbidity, Toxicity, Graft Versus Host Disease Or New Autoimmunity

Christoph Simon, Nora Mirza, Wolfgang A. Bethge, MD, Wichard Vogel, MD, Christoph Faul, MD, Hans-Georg Rammensee, Lothar Kanz, MD, Sebastian P. Haen, MD

Blood (2013) 122 (21): 2069.

https://doi.org/10.1182/blood.V122.21.2069.2069

Published: 2013

Journal Articles

Enhanced Myeloid and T Cell Development and Improved Functionality of Cord Blood Xenografts In the NSGS Mouse.

Mark Wunderlich, M.S., Pietro Presicce, PhD, Fu-Sheng Chou, M.D., Claire Chougnet, PhD, Julio Aliberti, PhD, James C. Mulloy, PhD

Blood (2010) 116 (21): 3729.

https://doi.org/10.1182/blood.V116.21.3729.3729

Published: 2010

Journal Articles

Haploidentical Stem Cell Transplantation for Children with High-Risk Leukemia In Chile: Report of the First 15 Cases.

Julia I Palma, MD, Lucia Salas, MT, Flavio Carrion, PhD, Cristián Sotomayor, MD, Paula Catalán, Rupert Handgretinger, MD, PhD, Gaston Rivera, MD

Blood (2010) 116 (21): 4581.

https://doi.org/10.1182/blood.V116.21.4581.4581

Published: 2010

Journal Articles

Pentostatin and Alemtuzumab: An Immunosuppressive Nonmyeloablative Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).

Faiz Anwer, MD, Michael P. Carroll, MD, Myke R. Green, PharmD, Lee Cranmer, MD, PhD, Leona Downey, MD, Linda Garland, MD, Katayoun Moini, MHS, PA-C, Daniel O. Persky, MD, Rachel Swart, MD, PhD, Andrew M. Yeager, MD

Blood (2009) 114 (22): 4312.

https://doi.org/10.1182/blood.V114.22.4312.4312

Published: 2009

NARROW

Intraocular toxoplasmosis mimicking vitreous lymphoma

Opportunistic Infections, Is Non Hodgkin Lymphoma One of the Risk Factors for Mortality?

Neurological Adverse Events Determine Morbidity and Mortality Post Allogeneic Hematopoietic Cell Transplantation

Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group

Ruxolitinib Inhibits Toll-like Receptor or GM-CSF, but Not TREM-1 Mediated Neutrophil Activation

Impact of Somatic Mutations on Clinical Outcomes Following Flamsa-Bu Conditioning and Allogenic Stem Cell Transplantation in Patients with Poor-Risk Myeloid Malignancies

Cerebral Toxoplasmosis in a Patient with Prolonged CD4 Lymphopenia Post Autologous Haematopoietic Stem Cell Transplant

Transplantation from Matched Unrelated and Haploidentical Donor in Pediatric Severe Aplastic Anemia: Experience with TCR Alpha/Beta and CD19 Depletion As Graft Processing Method

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Disease and Therapy Associated Complications of the Central Nervous System after Allogeneic Hematopoietic Cell Transplantation - a Significant Proportion of Patients Will Suffer from Permanent Damage

Long Term Follow-up of Hematopoietic Stem Cell Transplantation (HSCT) for Primary Plasma Cell Leukemia (pPCL): Final Results of a Prospective Study of IFM Group

Seroprevalence for Toxoplasma Gondii in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Assessment of Incidence Toxoplasma Gondii Infection and Outcomes in Allogeneic Stem Cell Patients

Specificity of JAK-Kinase Inhibition Determines Impact on T-Cell Function

Neutropenia during Hematopoietic Stem Cell Mobilization with G-CSF

Infectious Complications After Unrelated Donor Allogeneic Hematopoietic Cell Transplantation With Or Without Alemtuzumab Based In Vivo Lymphocyte Depletion

Central Nervous System Complications After Allogeneic Hematopoietic Cell Transplantation – Treatment Related Morbidity, Toxicity, Graft Versus Host Disease Or New Autoimmunity

Enhanced Myeloid and T Cell Development and Improved Functionality of Cord Blood Xenografts In the NSGS Mouse.

Haploidentical Stem Cell Transplantation for Children with High-Risk Leukemia In Chile: Report of the First 15 Cases.

Pentostatin and Alemtuzumab: An Immunosuppressive Nonmyeloablative Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only